Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity

Схожие документы

• Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
  по: Sun, Kai, et al.
  Опубликовано: (2004)
• Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality
  по: Jasperson, Lisa K., et al.
  Опубликовано: (2009)
• Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation
  по: Welniak, Lisbeth A., et al.
  Опубликовано: (2006)
• Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)
  по: Taylor, Patricia A., et al.
  Опубликовано: (2007)
• Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation
  по: Sun, Kai, et al.
  Опубликовано: (2008)